| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263 [S. A., M. G. B.]; Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43614 [J. G.]; and Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555 [T. C. K.]
We examined transforming growth factor-ß1 (TGF-ß1) effects on cell cycle progression of human colon carcinoma FET cells. TGF-ß1 inhibited DNA synthesis and cyclin-dependent kinase (CDK) activity after release from growth arrest in association with induction of the p21 CDK inhibitor, whereas cyclins, CDKs, and p27 protein levels remained relatively unchanged. The decrease in CDK2 kinase activity was the result of increased p21 association with cyclin A-CDK2 and cyclin E-CDK2. TGF-ß1 treatment in late G1 showed reduced induction of p21 protein levels in association with increased DNA synthesis. Consequently, p21 induction in early G1 is critical for TGF-ß1 inhibition of CDK2 kinase activity. Although TGF-ß1 treatments in late G1 failed to induce p21 protein, p21 mRNA induction was observed in late G1 and in S phase. Further analysis showed that TGF-ß1 treatment in early G1 increases p21 protein stability throughout the G1 and S phases of the cell cycle. Our results demonstrate that TGF-ß1 stimulation of p21 is regulated at the posttranscriptional and transcriptional levels. This is a novel mechanism of TGF-ß1 inhibition requiring early G1 induction and stabilization of p21 protein, which binds to and inhibits cyclin E-CDK2 and cyclin A-CDK2 kinase activity rather than direct modulation of cyclin or CDK protein levels as seen in other systems.
This article has been cited by other articles:
![]() |
D.-S. Lee, J.-T. Park, H.-M. Kim, J. S. Ko, H.-H. Son, R. M. Gronostajski, M.-I. Cho, P.-H. Choung, and J.-C. Park Nuclear Factor I-C Is Essential for Odontogenic Cell Proliferation and Odontoblast Differentiation during Tooth Root Development J. Biol. Chem., June 19, 2009; 284(25): 17293 - 17303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. Yang, J. Yang, K. Kuropatwinski, W. Wang, X.-Q. Liu, J. Hauser, and M. G. Brattain Transforming Growth Factor {beta} Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells Cancer Res., May 1, 2008; 68(9): 3152 - 3160. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Lee, H. J. Kim, Y. S. Lee, H.-J. Park, J.-W. Choi, J. Ha, and K.-T. Lee Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte Carcinogenesis, September 1, 2007; 28(9): 1928 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Aneja, A. M. Ghaleb, J. Zhou, V. W. Yang, and H. C. Joshi p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells Cancer Res., April 15, 2007; 67(8): 3862 - 3870. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Yen, Y.-H. Huang, C.-Y. Liao, C.-J. Liao, W.-L. Cheng, W.-J. Chen, and K.-H. Lin Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta J. Mol. Endocrinol., February 1, 2006; 36(1): 9 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy and C. S. Hill Smad4 Dependency Defines Two Classes of Transforming Growth Factor {beta} (TGF-{beta}) Target Genes and Distinguishes TGF-{beta}-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses Mol. Cell. Biol., September 15, 2005; 25(18): 8108 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, Y. Muragaki, Y. Okada, T. Miyamoto, Y. Ohnishi, A. Ooshima, and W. W.-Y. Kao Sonic Hedgehog Expression and Role in Healing Corneal Epithelium Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2577 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ammanamanchi, M. P. M. Tillekeratne, T. C. Ko, and M. G. Brattain Endogenous Control of Cell Cycle Progression by Autocrine Transforming Growth Factor {beta} in Breast Cancer Cells Cancer Res., April 1, 2004; 64(7): 2509 - 2515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |